~taiho
What is the median overall survival (mOS) for the overall study population?
What is the recommended dosage modification of INQOVI for patients with mild or moderate renal impairment?
What approvals has INQOVI received?
What precautions should be taken for pregnant women during treatment with LONSURF?
What treatment options are recommended for patients who have progressed through all available regimens?
What is the goal of the collaboration between Astex Pharmaceuticals and MD Anderson Cancer Center?
How many patients will be enrolled in the REZILIENT3 trial?
What precautions should be taken when using INQOVI?
Is it safe for women to breastfeed during treatment with INQOVI?
What are the important safety warnings and precautions for LONSURF?
What is the indication for INQOVI?
What is the purpose of the phase I dose-escalation study?
What is the purpose of the ASCERTAIN phase 3 trial?
What are the treatment options for patients who have progressed through all available regimens?
What is the corporate philosophy of the Otsuka Group?
